It sounded like you were doing a bit more than just posing :- )
In general, your posts strike me as somewhat gullible with respect to VRUS’ talking points. VRUS is a fine company that has a nice portfolio of HCV drugs, but they do not have anything radically different from the pyrimidine and purine nukes of other HCV companies.
Market Data 
Markets 
AI
